Welcome to the e-CCO Library!

P296: Evaluation of the new liaison faecal calprotectin assay
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

N. Hammoudi1, H. Manceau2, C. Stefanescu1, D. Debuyser2, Y. Bouhnik1, 3, H. Puy2, 3, K. Peoc’h*2, 3

Created: Friday, 22 February 2019, 9:49 AM
P296: Levels of engagement in physical activity and fatigue in IBD patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Gatt1*, J. Schembri1, K.H. Katsanos2, D.K. Christodoulou2, D. Balomenos2, K. Karmiris3, C. Pontas4, U. Kopylov5, I. Koutroubakis6, K. Foteinogiannopoulou6, A. Fábián7, T. Molnár7, D. Zammit1, P. Ellul1, G.J. Mantzaris4

Created: Thursday, 21 February 2019, 9:14 AM
P296: MAGNIFI-CD index is appropriate for treatment monitoring in perianal Crohn's Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Beek, K.(1);Mulders, L.(2)*;Tielbeek, J.(1);Horsthuis, K.(1);Buskens, C.(3);D'Haens, G.(2);Gecse, K.(2);Stoker, J.(1);
Created: Friday, 14 July 2023, 11:05 AM
P296: Persistent symptoms, CRP elevation and treatment changes over time in Crohn's disease patients are associated with bowel damage progression as expressed by deterioration of Lemann Index score
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zezos P.*1, Chawla T.P.2, Weizman A.V.1, Nguyen G.C.1, Narula N.1, Kabakchiev B.3, Milgrom R.3, Croitoru K.1, Steinhart A.H.1, Silverberg M.S.1

Created: Wednesday, 20 February 2019, 10:36 AM
P296: Stopping 5-aminosalicylic acid in patients with ulcerative colitis who are in clinical remission does not increase risks of flare
Year: 2021
Source: ECCO'21 Virtual
Authors: Mak, J.W.Y.(1);Yuen, N.T.K.(1);Yip, T.C.F.(1);Lam, R.H.M.(1);Lam, B.K.H.(1);Chan, F.K.L.(1);Ng , S.C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P297 Novel serum soluble markers of histological healing in ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

O.M. Nardone1, L. Jeffery1, A. Bazarova2, A. Acharjee3, G. Gkoutos3, D. Zardo4, U.N. Shivaji1, S.C. Smith1, S. Ghosh1, M. Iacucci1

Created: Thursday, 30 January 2020, 10:12 AM
P297: Evaluation of the clinical course of Adolescent inflammatory bowel disease patients at Nottingham University Hospital
Year: 2018
Source: ECCO '18 Vienna
Authors:

D.-c. Osei-Bordom*, A.A. Thi, E. Williams, N. Yusoff, N. Ahmad, T. Horne, F. Abbasi, Y. Mildrid, D. Devadason, E. Simon, T. Card, G. Moran

Created: Thursday, 21 February 2019, 9:14 AM
P297: Fecal calprotectin accurately predicts symptomatic relapse in children and adolescents with inflammatory bowel disease in clinical remission
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Diederen K.*1, Hoekman D.1, Leek A.2, Wolters V.2, Benninga M.1, Hummel T.3, de Meij T.4, Koot B.1, Tabbers M.1, Benninga M.1, Kindermann A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P297: HLA-DQA1*05 allele and its association with the secondary loss of response to infliximab in patients with Inflammatory Bowel Disease.
Year: 2021
Source: ECCO'21 Virtual
Authors: Angulo McGrath, I.(1);Bracho González, M.(1);Ocaña Ledesma, A.(1);Olmedo Martín, R.V.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P297: The change of bone mineral density in patients with inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

W. Moon*1, S. J. Park1, M. I. Park1, S. E. Kim1, J. H. Kim1, K. Jung1

Created: Friday, 22 February 2019, 9:41 AM
P297: The Toronto IBD Global Endoscopic Reporting (TIGER) Score and its Ability to Predict Outcomes Regarding Steroid and Biologic Use in Ulcerative Colitis and Crohn's Disease Patients – A Construct Validation Study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Zittan, E.(1,2,3)*;Levy, M.(1,2);Saban , L.(1); Vered, S.(4); Steinhart, A.H.(5); Milgrom, R.(5); Gralnek, I.M.(1,2); Silverberg, M.S.(5); Zelber-Sagi, S.(3);
Created: Friday, 14 July 2023, 11:05 AM
P297: Treatment of patients with complex perianal Crohn's disease with darvadstrocel: a single-institution real life experience.
Year: 2022
Source: ECCO'22
Authors: BorruelPhD, N.(1);Martí, M.(2);Armario, D.(3);Ibarz, A.(1);Robles, V.(1);Herrera, C.(1);Mayorga, L.(1);Pérez, Z.(1);Alonso, C.(4);Elena, C.(1);Planes, M.(3);Oller, E.(1);Espín, E.(5);Casellas, F.(1);
Created: Friday, 11 February 2022, 3:52 PM
P297: Ulcerative colitis and proximal extension of the disease: a sub-group with worse prognosis?
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Sousa*, D. Martins, J. Pinho, R. Araújo, E. Cancela, A. Castanheira, P. Ministro, A. Silva

Created: Friday, 22 February 2019, 9:49 AM
P298 Patient-reported outcomes: the ICHOM standard set for IBD in real-life practice helps quantify deficits in current care
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Wong, R. Kantschuster, L. Matini, D. Simadibrata, M. Lepetyukh, J. Wilson, O. Brain, R. Palmer, T. Ambrose, J. Satsangi, S. Travis, A.J. Walsh

Created: Thursday, 30 January 2020, 10:12 AM
P298: Budesonide MMX versus Prednisolone for Ulcerative Colitis: Comparative outcomes from a British retrospective multi-centre study
Year: 2021
Source: ECCO'21 Virtual
Authors: Rosiou , K.(1);Ong Ming San , E.(1);Kumar , A.(2);Esquivel , K.(2);Almas , S.(2);Stokes , D.(2);Ng , T.(3);Jayasooriya , N.(3);Ranasinghe , I.(3);Pollok , R.(3);Brookes , M.(2);Selinger , C.P.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P298: Comparison between clinical and patient-reported symptoms among Crohn's disease and ulcerative colitis patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Pittet V.*1, Maillard M.H.2, Rogler G.3, Michetti P.4

Created: Wednesday, 20 February 2019, 10:36 AM
P298: Comparison of the familial and sporadic cases of inflammatory bowel diseases in long-term follow-up regarding step-up treatment, clinical, and biochemical parameters
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Bozcan*, I. Hatemi, Y. Erzin, G. Ayan, A. Satman, T. Gundogdu, K. Atay, N. Demir, A.F. Celik

Created: Friday, 22 February 2019, 9:49 AM
P298: Crohn’s disease or intestinal tuberculosis: The unsolved enigma
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Elleuch, W. Dahmani*, A. Ben Slama, A. Hammami, H. Jaziri, A. Brahem, M. Ksiaa, A. Jmaa

Created: Thursday, 21 February 2019, 9:14 AM
P298: Pregnancy in Crohn's and Colitis - Observations, Levels and Outcomes Extension (PICCOLO-X) Study: Biological therapy reduces faecal calprotectin and the need for corticosteroids in pregnant women with Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Prentice, R.(1);Wright, E.(2);Flanagan, E.(2);Goldberg, R.(1);Prideaux, I.(1);Ross, A.(2);Burns, M.(1);Bell, S.(1);
Created: Friday, 11 February 2022, 3:52 PM